Our mission

Cervical cancer is the second leading cause of death for women worldwide; 85% of deaths occur in low and middle-income countries (LMICs), despite the fact that well-established interventions exist for pre-invasive disease.

Many low-resource countries lack the health care infrastructure required for the cytology-based screening and referral colposcopic diagnosis that have dramatically reduced the disease burden in wealthier countries. Our vision is to sustainably improve women's access to cancer prevention.